Melanoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
Not yet recruiting
  • Breast Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2022-01-04
    Jan 4, 2022
    N
    Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1384 more
    2022-01-13
    Jan 13, 2022
    N
    The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
    Recruiting
    • Melanoma
    • Intervention Arm
    • Control
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-01-13
    Jan 13, 2022
    N
    Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
    Enrolling by invitation
    • Melanoma
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-01-13
      Jan 13, 2022
      M
      A Model for Genetic Susceptibility: Melanoma
      Active, not recruiting
      • Melanoma
      • Skin Cancer
      • Questionnaire
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      2022-01-13
      Jan 13, 2022
      C
      Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
      Recruiting
      • Lung Neoplasms
      • +12 more
      • CK-301 (cosibelimab)
      • Wollongong, New South Wales, Australia
      • +47 more
      2022-01-11
      Jan 11, 2022
      C
      CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
      Recruiting
      • Melanoma
      • +3 more
      • Phoenix, Arizona
      • +15 more
      2022-01-12
      Jan 12, 2022
      I
      LUMINOS-102: Lerapolturev (PVSRIPO) With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma
      Recruiting
      • Melanoma
      • Lerapolturev
      • Anti-PD-1 Checkpoint Inhibitor
      • Scottsdale, Arizona
      • +21 more
      2022-01-12
      Jan 12, 2022
      A
      Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
      Recruiting
      • Advanced Solid Tumors
      • +12 more
      • Continue PD-1/PD-L1 Inhibitors treatment
      • Discontinue PD-1/PD-L1-1 inhibitor
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      2021-12-22
      Dec 22, 2021
      B
      A Study to Test How BI 765063 is Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
      Recruiting
      • Carcinoma, Squamous Cell of Head and Neck (HNSCC)
      • +2 more
      • BI 765063
      • +2 more
      • Amsterdam, Netherlands
        Amsterdam UMC Locatie VUMC
      2022-01-11
      Jan 11, 2022
      D
      DAY101 Monotherapy or in Combination With Other Therapies for Patients With Solid Tumors
      Recruiting
      • Melanoma
      • Solid Tumor
      • Los Angeles, California
      • +6 more
      2022-01-10
      Jan 10, 2022
      D
      NeoVax + CDX-301 and Nivolumab in Advanced Melanoma
      Not yet recruiting
      • Melanoma
      • Metastatic Melanoma
      • Boston, Massachusetts
      • +1 more
      2022-01-11
      Jan 11, 2022
      N
      Collecting Solid Tumor Tissue to Identify New Treatments
      Completed
      • Gastrointestinal Cancer
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-01-11
        Jan 11, 2022
        V
        Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
        Recruiting
        • Melanoma
        • Tissue and blood collection
        • Nashville, Tennessee
          Vanderbitl-Ingram Cancer Center
        2022-01-11
        Jan 11, 2022
        N
        Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
        Active, not recruiting
        • Prostate Cancer
        • +4 more
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          2022-01-11
          Jan 11, 2022
          N
          Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
          Active, not recruiting
          • Melanoma
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-01-11
            Jan 11, 2022
            S
            Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
            Recruiting
            • Melanoma
            • Non-small Cell Lung Cancer
            • Tucson, Arizona
            • +24 more
            2022-01-07
            Jan 7, 2022
            J
            Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
            Recruiting
            • Renal Cell Carcinoma
            • +4 more
            • Phase Ib ARRY-614 + nivolumab
            • +4 more
            • Pittsburgh, Pennsylvania
              UPMC Hillman Cancer Center
            2022-01-09
            Jan 9, 2022
            S
            A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
            Recruiting
            • Small Cell Lung Cancer
            • +8 more
            • ladiratuzumab vedotin
            • Chandler, Arizona
            • +64 more
            2022-01-07
            Jan 7, 2022
            G
            A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Atezolizumab in Patients With NRAS-mutant Advanced Melanoma.
            Recruiting
            • Melanoma
            • Orange, California
            • +20 more
            2022-01-07
            Jan 7, 2022
            A
            A Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
            Recruiting
            • Unresectable or Metastatic Melanoma or Advanced Solid Tumors
            • +13 more
            • Tucson, Arizona
            • +15 more
            2022-01-07
            Jan 7, 2022
            A
            A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies - 2021
            Completed
            • Non-small Cell Lung Cancer
            • +11 more
            • Scottsdale, Arizona
            • +14 more
            2021-12-21
            Dec 21, 2021
            N
            A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
            Recruiting
            • NSCLC, Non Small Cell Lung Cancer
            • +9 more
            • Santa Monica, California
            • +22 more
            2022-01-10
            Jan 10, 2022
            E
            A Study to Assess YH003 in Combination With Toripalimab(Anti-PD-1 mAb) Injection in Patients With Cancers
            Recruiting
            • Melanoma
            • Pancreatic Ductal Adenocarcinoma
            • Richmond, Victoria, Australia
              Epworth Medical Centre
            2021-12-22
            Dec 22, 2021
            M
            Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)
            Active, not recruiting
            Has Results
            • Melanoma
            • Pembrolizumab
            • (no location specified)
            2021-11-12
            Nov 12, 2021